Behrang Shiri Varnamkhasti

Statistics

Publications

Citations

495

H-Index

Active since

2015

Affiliations

Tehran University of Medical Sciences(Current)

Kermanshah University of Medical Sciences

University of Tehran

Atomic Energy Organization of Iran

Academic Center for Education, Culture and Research

Behrang Shiri Varnamkhasti is an author at Tehran University of Medical Sciences specializing in nanomedicine, pharmaceutics, and cancer nanomedicine.

ORCID

Publications per year

2015–2022

Publications

Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer

Morteza Azhdarzadeh, Fatemeh Atyabi, Amir Ata Saei et al. · Colloids and Surfaces B Biointerfaces · 2016 · 160 citations

Pharmacy, Oncology, Pharmaceutics +17

Protein corona hampers targeting potential of MUC1 aptamer functionalized SN-38 core–shell nanoparticles

Behrang Shiri Varnamkhasti, Hosniyeh Hosseinzadeh, Morteza Azhdarzadeh et al. · International Journal of Pharmaceutics · 2015 · 99 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +14

SN38 conjugated hyaluronic acid gold nanoparticles as a novel system against metastatic colon cancer cells

Hosniyeh Hosseinzadeh, Fatemeh Atyabi, Behrang Shiri Varnamkhasti et al. · International Journal of Pharmaceutics · 2017 · 61 citations

Life Sciences, Oncology, Pharmaceutics +16

Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer

Mehdi Esfandyari‐Manesh, Ali Mohammadi, Fatemeh Atyabi et al. · International Journal of Pharmaceutics · 2016 · 54 citations

Pharmacy, Oncology, Pharmaceutics +12

Dual loading of <i>Nigella sativa</i> oil-atorvastatin in chitosan–carboxymethyl cellulose nanogel as a transdermal delivery system

Fereshteh Bagheri, Sara Darakhshan, Saharnaz Mazloomi et al. · Drug Development and Industrial Pharmacy · 2021 · 31 citations

Pharmacy, Pharmaceutics, Pharmacology +17

1–5 of 12